Patients receiving androgen deprivation therapy for prostate cancer have an increased risk of depressive disorder

Androgen deprivation therapy (ADT) results in testosterone suppression, a hypothesized mechanism linking ADT to depressive symptoms. This study investigated the relationship between ADT and the risk of subsequently being diagnosed with depressive disorder (DD) during a 3-year follow-up period. The p...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Shiu-Dong, Kao, Li-Ting, Lin, Herng-Ching, Xirasagar, Sudha, Huang, Chung-Chien, Lee, Hsin-Chien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333913/
https://www.ncbi.nlm.nih.gov/pubmed/28253340
http://dx.doi.org/10.1371/journal.pone.0173266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333913/
https://www.ncbi.nlm.nih.gov/pubmed/28253340
http://dx.doi.org/10.1371/journal.pone.0173266

Ejemplares similares